“The United States has announced plans to phase out its PEPFAR HIV/AIDS funding in South Africa, citing policy disagreements with Pretoria. UNAIDS warns that the decision could undermine decades of progress and jeopardize the lives of millions living with HIV in the country.”
South Africa, home to the largest population of people living with HIV globally, faces a looming public health crisis following the United States’ decision to initiate a phased withdrawal of funding under the President’s Emergency Plan for AIDS Relief (PEPFAR). The announcement has sparked widespread concern among health experts, civil society, and international organizations, with UNAIDS Executive Director Winnie Byanyima publicly urging Washington to reconsider the move. She warned that the funding cut could reverse decades of progress in combating HIV/AIDS and cost countless lives.
PEPFAR has been a cornerstone of South Africa’s HIV/AIDS response since its inception in 2003. At its peak, the program provided over $400 million annually, covering salaries for approximately 15,000 health workers and contributing up to 17% of the country’s HIV funding. While South Africa has made strides in financing its own HIV programs, the scale of the epidemic—affecting nearly 8 million people—means international support remains critical. UNAIDS has emphasized that withdrawing this assistance without a carefully planned transition risks destabilizing treatment and prevention services.
The U.S. State Department justified the decision by stating that South Africa, as a middle-income country, is capable of sustaining its own health programs. Officials also cited Pretoria’s failure to meet certain policy requests, including reducing ties with Iran, revising Black Economic Empowerment policies, and addressing controversial anti-apartheid chants. These conditions, however, have been criticized as political demands unrelated to public health, raising questions about the intersection of foreign policy and humanitarian aid.
Byanyima’s appeal highlights the human cost of the funding cut. “Taking it away is taking away life-saving support from the most vulnerable people,” she said, underscoring that millions rely on consistent access to antiretroviral therapy. Globally, 32.1 million of the 40 million people living with HIV are on treatment, a milestone achieved through sustained international cooperation. Disruptions in funding could jeopardize South Africa’s ability to maintain this progress and derail the global target of ending AIDS as a public health threat by 2030.
Civil society organizations in South Africa have echoed these concerns, warning that reduced funding will disproportionately affect marginalized communities, including women, youth, and rural populations. Many fear that the withdrawal will exacerbate existing inequalities in healthcare access, particularly in provinces already struggling with resource constraints. Health workers supported by PEPFAR have played a vital role in delivering services at community level, and their potential loss could leave gaps in care.
The broader context is equally troubling. Development assistance from traditional donors in Europe and North America has declined sharply in recent years, leaving countries like South Africa vulnerable to shifts in foreign policy priorities. The U.S. decision reflects a trend of shrinking global aid budgets, which threatens to undermine collective efforts against communicable diseases. Experts caution that without sustained investment, gains made in reducing HIV transmission and mortality could be undone.
South Africa’s government has yet to issue a detailed response, but officials are expected to engage in diplomatic discussions to mitigate the impact. Analysts suggest that Pretoria may need to increase domestic funding for HIV programs, though this will be challenging given economic pressures and competing priorities. Partnerships with private sector actors and regional organizations may also become more important in filling the gap.
The situation underscores the fragility of global health progress when dependent on external funding. UNAIDS and other stakeholders are calling for a “planned transition” rather than abrupt withdrawal, emphasizing that lives are at stake. As Byanyima noted, “Please do not take money away because you are taking lives away.” The coming months will be critical in determining whether South Africa can safeguard its HIV/AIDS response amid shifting international dynamics.
